MNKD MannKind Corporation - Common Stock
$3.90
Price · Aug 18, 2026
Fundamentals as of Aug 5, 2026
52W Range
$2–$7
39% of range
Analyst Rating
BUY
14 analysts
Price Target
$8
+105% upside
P/E (TTM)
194.8
ROE
-11.1%
Net Profit Margin
1.7%
About MannKind Corporation - Common Stock Company overview from Wikipedia
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
Read more
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann.
History
Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology. Pharmaceutical Discovery was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).
The FDA approved Afrezza on June 27, 2014.
On August 11, 2014 MannKind entered into an exclusive global licensing agreement with Sanofi for Afrezza sales. Under the agreement, MannKind received $150 million cash from Sanofi, in exchange for sharing profits and losses of sales of Afrezza, with 65% for Sanofi and 35% for MannKind. On January 5, 2016, MannKind Corporation announced the termination of the license and collaboration agreement with Sanofi. By December 2017, the company had lost 11% of its trading volume due to the poor sales.
In March 2020, the company announced it was working with fellow pharmaceutical company Immix Biopharma to try to develop an inhalable treatment for acute respiratory distress syndrome, a lung disease.
Products and product candidates
The firm has developed Afrezza a rapid-acting insulin peaking 12 to 15 minutes after inhalation and exiting the body within 2–3 hours. The inhalation technology uses a miniature, breath-powered inhaler in combination with single-use cartridges containing pre-metered doses. Initial pharmacokinetic studies were followed by studies of safety and efficiency involving Technosphere formulations of different therapeutic proteins.
Leadership
Mann was chief executive officer until January 12, 2015 when Hakan Edstrom became CEO and Mann transitioned to executive chairman.
In November 2015, Hakan Edstrom stepped down as CEO and president. Company founder Alfred Mann stepped in as interim CEO on November 19, 2015. In 2016, Matthew Pfeffer was appointed CEO of MannKind, and served as both CEO and CFO. In May 2017, Michael Castagna was named CEO of the company.
Facilities
MannKind has a large corporate office in Westlake Village, California. The Afrezza manufacturing facility is in Danbury, Connecticut. In 2022, the company moved its official headquarters to Danbury.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
MNKD Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.90
Market Cap
$1.20B
P/E (TTM)
194.8
EPS (TTM)
$0.02
Revenue (TTM)
$349M
Div Yield
—
ROE
-11.1%
Debt/Equity
—
52W Range
$2 – $7
MNKD Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$349M
2016-12-31
→
2025-12-31
EPS
$0.02
2016-12-31
→
2025-12-31
Free Cash Flow
$14M
2018-12-31
→
2025-12-31
Margins
1.7%
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
MNKD
Peer Median
P/E (TTM)
194.8
—
P/S (TTM)
3.4
10.7
P/B
-23.5
5.2
Price / FCF
87.6
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
MNKD
Peer Median
Operating Margin
11.1%
—
Net Profit Margin
1.7%
-140.3%
ROA
0.99%
-44.7%
ROE
-11.1%
-51.5%
ROIC
-316.9%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
MNKD
Peer Median
Current Ratio
1.7
9.5
Quick Ratio
1.2
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
MNKD
Peer Median
Revenue YoY
22.2%
—
Revenue CAGR 3Y
51.8%
—
Revenue CAGR 5Y
39.9%
—
EPS YoY
-80.0%
—
Net Income YoY
-78.8%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
MNKD
Peer Median
MNKD Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
14 analysts
- Strong Buy 4 28.6%
- Buy 8 57.1%
- Hold 2 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
8 analysts · 2026-08-17
Median
$7.50
← Below all targets
$3.90
Low
$4.75
High
$13.00
Median target
$7.50
+92.6%
Mean target
$7.97
+104.6%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.03%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.06 | $-0.00 | -0.06% |
| March 31, 2026 | $-0.05 | $-0.00 | -0.05% |
| Dec. 31, 2025 | $-0.05 | $0.01 | -0.06% |
| Sept. 30, 2025 | $0.07 | $0.02 | 0.05% |
| June 30, 2025 | $0.00 | $0.05 | -0.05% |
| March 31, 2025 | $0.04 | $0.04 | -0.00% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 16
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Cost of Revenue | $27M | $17M | $21M | $16M | $17M | $15M | $20M | $19M | $17M | $17M | $65M | · | |
| SG&A Expense | $144M | $94M | $94M | $91M | $32M | $25M | $75M | $80M | $75M | $47M | $41M | $79M | |
| Operating Expenses | $88M | $77M | $63M | $57M | $39M | $25M | $108M | $104M | $120M | $107M | $345M | $180M | |
| Operating Income | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-108M | $67M | $-345M | $-180M | |
| Interest Expense | · | · | $15M | $15M | $15M | · | · | · | · | · | $24M | $20M | |
| Interest Income | $8M | $13M | $6M | $3M | $112.0K | $167.0K | $997.0K | $501.0K | $293.0K | $85.0K | $18.0K | $9.0K | |
| Other Non-op | $-1M | $32.0K | $122.0K | $-102.0K | $-239.0K | $23.0K | $-926.0K | $-437.0K | $13.0K | $-597.0K | $1M | $2M | |
| Pretax Income | $1M | $31M | $-10M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Income Tax | $-4M | $3M | $2M | $0 | $0 | $-218.0K | $0 | $240.0K | $51.0K | $0 | $0 | $0 | |
| Net Income | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| EPS (Basic) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.37 | $-4.54 | $-2.57 | |
| EPS (Diluted) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.36 | $-4.54 | $-2.57 | |
| Shares (Basic) | 305,639,000 | 274,415,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,053,000 | 81,233,000 | 77,045,000 | |
| Shares (Diluted) | 314,112,000 | 283,844,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,085,000 | 81,233,000 | 77,045,000 | |
| EBITDA | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-106M | · | $-334M | $-170M |
Balance Sheet 28
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $75M | $46M | $238M | $70M | $124M | $67M | $30M | $71M | $44M | $23M | $59M | $121M | |
| Short-term Investments | $96M | $151M | $57M | $101M | $80M | $0 | $20M | · | · | · | · | · | |
| Receivables | $38M | $12M | $15M | $17M | $5M | $4M | $4M | $4M | $3M | $302.0K | $23.0K | $50M | |
| Inventory | $35M | $28M | $29M | $22M | $7M | $5M | $4M | $4M | $3M | $2M | · | $10M | |
| Prepaid Expense | $47M | $31M | $35M | $25M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $20M | |
| Current Assets | $292M | $268M | $373M | $235M | $219M | $79M | $61M | $82M | $57M | $77M | $77M | $201M | |
| PP&E (Net) | $82M | $85M | $84M | $45M | $37M | $26M | $27M | $26M | $27M | $29M | $49M | $192M | |
| PP&E (Gross) | $196M | $192M | $186M | $144M | $134M | $123M | $122M | $126M | $128M | $129M | $168M | $310M | |
| Accum. Depreciation | $114M | $107M | $102M | $99M | $98M | $97M | $95M | $100M | $101M | $100M | $120M | $118M | |
| Goodwill | $68M | $2M | $2M | $2M | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $5M | $1M | $1M | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $20M | $27M | $7M | $10M | $8M | $3M | $6M | $249.0K | $437.0K | $648.0K | $1M | $848.0K | |
| Total Assets | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Accounts Payable | $9M | $7M | $10M | $11M | $7M | $6M | $5M | $5M | $7M | $3M | $16M | $7M | |
| Accrued Liabilities | $65M | $40M | $42M | $36M | $27M | $20M | $16M | $15M | $12M | $8M | $8M | $26M | |
| Short-term Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Current Liabilities | $171M | $82M | $104M | $67M | $48M | $74M | $66M | $75M | $88M | $92M | $268M | $403M | |
| Capital Leases | $11M | $12M | $4M | $5M | $1M | $1M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $5M | · | · | · | · | · | $15M | $12M | |
| Total Liabilities | $843M | $473M | $721M | $546M | $531M | $289M | $284M | $283M | $299M | $291M | $477M | $468M | |
| Long-term Debt | $355M | $36M | $269M | $273M | $281M | $122M | $119M | $102M | $157M | · | · | · | |
| Total Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $4M | $4M | |
| Retained Earnings | $-3.20B | $-3.20B | $-3.23B | $-3.22B | $-3.13B | $-3.05B | $-2.99B | $-2.94B | $-2.85B | $-2.74B | $-2.86B | $-2.49B | |
| AOCI | $115.0K | $1M | · | · | · | · | $-19.0K | $-19.0K | $-18.0K | $-24.0K | $-20.0K | $-14.0K | |
| Stockholders' Equity | $-51M | $-79M | $-246M | $-251M | $-209M | $-180M | $-191M | $-175M | $-215M | $-184M | $-350M | $-74M | |
| Liabilities + Equity | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Shares Outstanding | 307,832,587 | 302,959,782 | 270,034,495 | 263,793,305 | 251,477,562 | 242,117,089 | 211,787,573 | 187,029,967 | 119,053,414 | 95,680,831 | 85,734,188 | 406,059,089 |
Cash Flow 18
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $7M | $5M | $3M | $2M | $2M | $972.0K | $3M | $2M | $2M | $11M | $10M | |
| Stock-based Comp | $24M | $21M | $18M | $13M | $12M | $7M | $6M | $7M | $5M | $5M | $9M | $49M | |
| Deferred Tax | $-19M | $4M | $7M | $-10M | $-20M | $-5M | $-5M | $-11M | $-260M | $48M | $-80M | $-66M | |
| Amort. of Intangibles | $4M | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $6M | $2M | |
| Other Non-cash | · | · | · | · | · | · | · | · | $306M | · | $291M | $144M | |
| Operating Cash Flow | $18M | $43M | $34M | $-81M | $-62M | $-28M | $-88M | $-38M | $-65M | $-78M | $-57M | $4M | |
| CapEx | $5M | $10M | $42M | $8M | $11M | $801.0K | $3M | $354.0K | · | $1M | $10M | $24M | |
| Investing Cash Flow | $-305M | $-97M | $-2M | $5M | $-152M | $15M | $-23M | $-234.0K | $17M | $-1M | · | · | |
| Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | $20M | |
| Net Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $564.0K | $893.0K | $28M | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $564.0K | · | $28M | · | |
| Financing Cash Flow | $315M | $-137M | $137M | $21M | $270M | $50M | $70M | $61M | $74M | $43M | · | · | |
| Net Change in Cash | $29M | $-191M | $169M | $-54M | $57M | $37M | $-41M | $23M | $25M | $-36M | $-62M | $50M | |
| Taxes Paid | $2M | $4M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $14M | $33M | $-8M | $-88M | $-73M | $-29M | $-91M | $-38M | · | · | $-68M | $-20M | |
| Levered FCF | · | · | $-26M | $-98M | · | · | · | · | · | · | $-92M | · |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -921.1% | · | · | · | |
| Net Margin | 1.7% | 9.7% | -6.0% | -87.6% | -107.3% | -87.9% | -82.3% | -312.2% | -999.0% | · | · | · | |
| Pretax Margin | 0.40% | 10.7% | -5.2% | -87.6% | -107.3% | -88.2% | -82.3% | -311.3% | -998.6% | · | · | · | |
| EBITDA Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -905.8% | · | · | · | |
| ROA | 0.99% | 6.3% | -3.1% | -28.4% | -37.7% | -56.6% | -51.5% | -90.5% | -122.4% | · | -141.5% | -60.8% | |
| ROE | -11.1% | -19.1% | 4.8% | 35.8% | 41.1% | 31.2% | 27.7% | 45.7% | 58.9% | · | 173.8% | 379.7% | |
| ROIC | -316.9% | -83.2% | -4.1% | 25.6% | 22.5% | 26.5% | 24.0% | 43.9% | 50.4% | · | 98.4% | · |
Liquidity & Solvency 4
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 | 1.1 | 0.9 | 1.1 | 0.7 | · | 0.3 | 0.5 | |
| Quick Ratio | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 | 1.0 | 0.8 | 1.0 | 0.5 | · | 0.2 | 0.4 | |
| Debt / Equity | · | · | · | · | · | · | -0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | 0.6 | -6.7 | · | · | · | · | · | · | -14.3 | -8.8 |
Efficiency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.6 | 0.3 | 0.1 | · | 0.0 | · | |
| Inventory Turnover | 0.8 | 0.6 | 0.8 | 1.1 | 2.8 | 3.3 | 5.2 | 6.2 | 6.9 | · | · | · | |
| Receivables Turnover | 13.9 | 21.4 | 12.6 | 9.3 | 16.4 | 16.9 | 16.7 | 8.2 | 7.6 | · | 0.0 | · |
Growth Rates 5
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 22.2% | 43.5% | 99.4% | 32.2% | 15.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 51.8% | 55.8% | 45.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 39.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -80.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -78.8% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 13
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Net Income TTM | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Market Cap | $1.75B | $1.95B | $983M | $1.39B | $1.10B | $758M | $273M | $198M | $276M | · | $3.11B | $10.60B | |
| Enterprise Value | · | · | · | · | · | · | $228M | · | · | · | · | · | |
| P/E | 283.5 | 64.3 | -91.0 | -15.5 | -13.7 | -12.0 | -2.0 | -1.8 | -2.1 | 2.4 | -1.6 | -10.2 | |
| P/S | 5.0 | 6.8 | 4.9 | 13.9 | 14.6 | 11.6 | 4.3 | 7.1 | 23.5 | · | · | · | |
| P/B | -34.2 | -24.7 | -4.0 | -5.5 | -5.2 | -4.2 | -1.4 | -1.1 | -1.3 | · | -8.9 | -143.7 | |
| P / Cash Flow | 95.6 | 45.8 | 28.8 | -17.2 | -17.8 | -26.9 | -3.1 | -5.3 | -4.3 | · | -54.3 | 2593.8 | |
| P / FCF | 127.5 | 59.4 | -117.8 | -15.7 | -15.0 | -26.2 | -3.0 | -5.2 | · | · | -46.0 | -529.6 | |
| EV / EBITDA | · | · | · | · | · | · | -5.1 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | -2.5 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | 3.6 | · | · | · | · | · | |
| Earnings Yield | 0.35% | 1.6% | -1.1% | -6.5% | -7.3% | -8.3% | -48.8% | -56.6% | -48.7% | 42.5% | -62.6% | -9.8% |
Income Statement 16
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109M | $90M | $112M | $82M | $77M | $78M | $77M | $70M | $72M | $66M | $58M | $51M | $49M | $41M | $36M | $33M | |
| Cost of Revenue | $14M | $8M | $14M | $4M | $5M | $4M | $5M | $3M | $6M | $4M | $6M | $4M | $5M | $6M | $4M | $5M | |
| SG&A Expense | $58M | $54M | $58M | $29M | $32M | $25M | $24M | $24M | $24M | $22M | $61M | $11M | $12M | $11M | $64M | $9M | |
| Operating Expenses | $30M | $92M | $-103M | $63M | $21M | $56M | $-86M | $57M | $56M | $50M | $18M | $14M | $14M | $16M | $16M | $17M | |
| Operating Income | $-350.0K | $-2M | $-8M | $19M | $5M | $22M | $26M | $13M | $17M | $17M | $8M | $5M | $2M | $-6M | $-13M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | $6M | $3M | · | $3M | $7M | $3M | · | $3M | |
| Interest Income | $1M | $1M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $663.0K | |
| Other Non-op | $-5M | $-3M | $23M | $-11M | $-4M | $-9M | $24M | $110.0K | $-18M | $-6M | $-164.0K | $318.0K | $-143.0K | $111.0K | $105.0K | $-207.0K | |
| Pretax Income | $-19M | $-16M | $-21M | $8M | $940.0K | $14M | $8M | $13M | $-2M | $11M | $3M | $2M | $-5M | $-10M | $-18M | $-14M | |
| Income Tax | $-106.0K | $253.0K | $-5M | $-204.0K | $272.0K | $459.0K | $1M | $1M | $323.0K | $264.0K | $2M | $0 | $0 | $0 | · | $0 | |
| Net Income | $-19M | $-17M | $-16M | $8M | $668.0K | $13M | $7M | $12M | $-2M | $11M | $1M | $2M | $-5M | $-10M | $-18M | $-14M | |
| EPS (Basic) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| EPS (Diluted) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| Shares (Basic) | 309,191,000 | 308,267,000 | -609,602,000 | 306,806,000 | 304,954,000 | 303,481,000 | -543,995,000 | 274,998,000 | 273,056,000 | 270,356,000 | -531,313,000 | 268,732,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| Shares (Diluted) | 309,191,000 | 308,267,000 | -629,907,000 | 311,638,000 | 311,484,000 | 320,897,000 | -598,638,000 | 284,693,000 | 273,056,000 | 324,733,000 | -586,351,000 | 323,770,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| EBITDA | · | $-2M | · | $19M | $5M | $22M | · | $13M | $17M | $17M | · | $5M | $2M | $-6M | · | $-10M |
Balance Sheet 25
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $53M | $53M | $75M | $127M | $57M | $47M | $46M | $62M | $97M | $193M | · | $83M | $86M | $86M | · | $54M | |
| Short-term Investments | $58M | $81M | $96M | $133M | $122M | $134M | $151M | $189M | $151M | $107M | · | $58M | $58M | $80M | · | $111M | |
| Receivables | $43M | $28M | $38M | $17M | $27M | $29M | $12M | $18M | $23M | $20M | · | $22M | $28M | $20M | · | $23M | |
| Inventory | $44M | $49M | $35M | $27M | $28M | $29M | $28M | $27M | $25M | $26M | · | $27M | $25M | $22M | · | $18M | |
| Prepaid Expense | $47M | $40M | $47M | $54M | $44M | $34M | $31M | $31M | $30M | $36M | · | $36M | $33M | $15M | · | $12M | |
| Current Assets | $246M | $251M | $292M | $359M | $279M | $274M | $268M | $328M | $326M | $383M | · | $226M | $230M | $223M | · | $218M | |
| PP&E (Net) | $85M | $83M | $82M | $83M | $83M | $84M | $85M | $85M | $85M | $84M | · | $80M | $70M | $55M | · | $41M | |
| PP&E (Gross) | $203M | $198M | $196M | $195M | $194M | $192M | $192M | $192M | $190M | $186M | · | $182M | $170M | $154M | · | $140M | |
| Accum. Depreciation | $118M | $116M | $114M | $113M | $111M | $109M | $107M | $107M | $105M | $103M | · | $101M | $100M | $100M | · | $99M | |
| Goodwill | $68M | $68M | $68M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $3M | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Other Non-current Assets | $17M | $22M | $20M | $19M | $20M | $28M | $27M | $26M | $16M | $7M | · | $8M | $8M | $16M | · | $17M | |
| Total Assets | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Accounts Payable | $11M | $16M | $9M | $7M | $10M | $5M | $7M | $6M | $10M | $7M | · | $17M | $17M | $14M | · | $10M | |
| Accrued Liabilities | $61M | $59M | $65M | $31M | $31M | $40M | $40M | $37M | $41M | $42M | · | $32M | $37M | $33M | · | $30M | |
| Current Liabilities | $143M | $135M | $171M | $109M | $112M | $116M | $82M | $72M | $80M | $100M | · | $96M | $97M | $82M | · | $60M | |
| Capital Leases | $10M | $10M | $11M | $10M | $11M | $11M | $12M | $12M | $3M | $4M | · | $4M | $5M | $5M | · | $6M | |
| Total Liabilities | $800M | $804M | $843M | $539M | $467M | $469M | $473M | $674M | $670M | $711M | · | $572M | $574M | $554M | · | $532M | |
| Long-term Debt | $319M | $319M | $355M | $110M | $36M | $36M | $36M | $228M | $228M | $264M | · | $273M | $274M | $274M | · | $273M | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $-3.23B | $-3.21B | $-3.20B | $-3.18B | $-3.19B | $-3.19B | $-3.20B | $-3.21B | $-3.22B | $-3.22B | · | $-3.23B | $-3.23B | $-3.23B | · | $-3.20B | |
| AOCI | $-19.0K | $-4.0K | $115.0K | $137.0K | $1M | $1M | $1M | $588.0K | · | · | · | $443.0K | $443.0K | · | · | $-1M | |
| Stockholders' Equity | $-67M | $-59M | $-51M | $-45M | $-55M | $-59M | $-79M | $-210M | $-226M | $-230M | $-246M | $-252M | $-260M | $-255M | $-251M | $-238M | |
| Liabilities + Equity | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Shares Outstanding | 309,911,682 | 308,907,331 | 307,832,587 | 307,027,189 | 306,332,133 | 303,918,969 | 302,959,782 | 275,775,038 | 274,467,247 | 270,801,781 | · | 269,543,539 | 268,235,145 | 264,278,760 | · | 263,156,165 |
Cash Flow 11
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $-427.0K | |
| Stock-based Comp | $10M | $6M | $7M | $4M | $8M | $5M | $6M | $5M | $6M | $4M | $4M | $5M | $6M | $4M | $3M | $4M | |
| Amort. of Intangibles | $4M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-18M | $-5M | $-8M | $24M | $9M | $-6M | $23M | $9M | $4M | $7M | $22M | $9M | $3M | $1M | $-2M | $-28M | |
| CapEx | $5M | $2M | $2M | $1M | $1M | $330.0K | $3M | $1M | $3M | $2M | $6M | $11M | $17M | $8M | $5M | $271.0K | |
| Investing Cash Flow | $18M | $19M | $-292M | $-25M | $6M | $6M | $48M | $-41M | $-55M | $-48M | $-8M | $-12M | $4M | $14M | $15M | $27M | |
| Financing Cash Flow | $559.0K | $-35M | $247M | $72M | $-6M | $1M | $-87M | $-2M | $-45M | $-3M | $142M | $-283.0K | $-6M | $1M | $3M | $20M | |
| Net Change in Cash | $97.0K | $-22M | $-53M | $70M | $10M | $975.0K | $-16M | $-34M | $-96M | $-45M | $155M | $-3M | $315.0K | $16M | $15M | $19M | |
| Taxes Paid | $753.0K | $63.0K | $549.0K | $80.0K | $869.0K | $207.0K | $2M | $236.0K | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-7M | · | · | · | $-7M | · | · | · | $4M | · | · | · | $-7M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $2M | · | · | · | $-10M | · | · |
Profitability 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| Net Margin | · | -18.4% | · | 9.7% | 0.87% | 16.8% | · | 16.5% | -2.8% | 16.0% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| Pretax Margin | · | -18.1% | · | 9.5% | 1.2% | 17.4% | · | 18.4% | -2.3% | 16.4% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| EBITDA Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| ROA | · | -2.9% | · | 1.7% | 0.16% | 2.9% | · | 2.9% | -0.53% | 2.7% | · | 0.56% | -1.8% | -3.2% | · | -5.4% | |
| ROE | · | 28.2% | · | -6.3% | -0.48% | -9.1% | · | -5.0% | 0.83% | -4.4% | · | -0.70% | 2.1% | 4.0% | · | 6.8% | |
| ROIC | · | 2.9% | · | -43.5% | -6.8% | -36.8% | · | -5.5% | -8.8% | -7.1% | · | -2.0% | -0.66% | 2.4% | · | · |
Liquidity & Solvency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 3.3 | 2.5 | 2.4 | · | 4.5 | 4.1 | 3.8 | · | 2.3 | 2.4 | 2.7 | · | 3.7 | |
| Quick Ratio | · | 1.2 | · | 2.5 | 1.8 | 1.8 | · | 3.7 | 3.4 | 3.2 | · | 1.7 | 1.8 | 2.3 | · | 3.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 2.7 | 6.5 | · | 1.8 | 0.3 | -2.5 | · | · |
Efficiency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.4 | |
| Receivables Turnover | 3.1 | 3.2 | · | 4.6 | 3.0 | 3.2 | · | 3.5 | 2.8 | 3.3 | · | 2.3 | 2.3 | 2.8 | · | 2.0 |
Valuation (TTM) 9
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $358M | $327M | · | $307M | $297M | $287M | · | $260M | $239M | $207M | · | $173M | $141M | $104M | · | $86M | |
| Net Income TTM | $-27M | $5M | · | $33M | $23M | $33M | · | $22M | $5M | $-3M | · | $-28M | $-59M | $-79M | · | $-74M | |
| Market Cap | $1.32B | $757M | · | $1.65B | $1.15B | $1.53B | · | $1.73B | $1.43B | $1.23B | · | $1.11B | $1.09B | $1.08B | · | $813M | |
| P/E | -53.2 | 122.5 | · | 48.8 | 53.4 | 45.7 | · | 78.6 | 261.0 | -453.0 | · | -37.5 | -17.7 | -13.2 | · | -10.7 | |
| P/S | 3.7 | 2.3 | · | 5.4 | 3.9 | 5.3 | · | 6.7 | 6.0 | 5.9 | · | 6.4 | 7.7 | 10.4 | · | 9.5 | |
| P/B | -19.6 | -12.8 | · | -37.0 | -20.8 | -26.1 | · | -8.3 | -6.3 | -5.3 | · | -4.4 | -4.2 | -4.2 | · | -3.4 | |
| P / Cash Flow | · | -141.1 | · | · | · | -239.7 | · | · | · | 183.0 | · | · | · | 937.3 | · | · | |
| P / FCF | · | -104.5 | · | · | · | -227.9 | · | · | · | 285.6 | · | · | · | -151.4 | · | · | |
| Earnings Yield | -1.9% | 0.82% | · | 2.1% | 1.9% | 2.2% | · | 1.3% | 0.38% | -0.22% | · | -2.7% | -5.7% | -7.6% | · | -9.4% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $349M | $286M | $199M | $100M | $75M |
| Operating Margin % | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% |
| Net Income | $6M | $28M | $-12M | $-87M | $-81M |
| Diluted EPS | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 |
| Quick Ratio | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $14M | $33M | $-8M | $-88M | $-73M |
Latest News Recent headlines mentioning this company
- Wells Fargo Calls MannKind Corporation (MNKD)’s Commercial Potential a “Show-Me Story”
- MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy
- H.C. Wainwright and Wells Fargo Lift MannKind (MNKD) Price Targets
- Is MannKind Corporation (MNKD) One of the Popular Penny Stocks on Robinhood to Buy?
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 271 filers · $560.6M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 55 (+12 vs prior Q) | 37 (-11 vs prior Q) | 93 (+10 vs prior Q) | 61 (-8 vs prior Q) | +24.2M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Rubric Capital Management LP | $76,680,000 | 18,000,000 | 13.68% | Shares |
| STATE STREET CORP | $68,901,423 | 16,174,043 | 12.29% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $56,101,610 | 13,169,392 | 10.01% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $29,027,881 | 6,812,460 | 5.18% | Shares |
| Frazier Life Sciences Management, L.P. | $28,116,000 | 6,600,000 | 5.01% | Shares |
| Deep Track Capital, LP | $25,560,000 | 6,000,000 | 4.56% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $23,099,232 | 5,422,355 | 4.12% | Shares |
| 180 WEALTH ADVISORS, LLC | $21,126,835 | 4,959,351 | 3.77% | Shares |
| FMR LLC | $17,455,563 | 4,097,550 | 3.11% | Shares |
| TSP Capital Management Group, LLC | $16,923,596 | 3,972,675 | 3.02% | Shares |
| BRAIDWELL LP | $14,732,908 | 3,458,429 | 2.63% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12,789,240 | 3,002,169 | 2.28% | Shares |
| VANGUARD GROUP INC | $11,888,249 | 2,096,693 | 2.12% | Shares |
| TWO SIGMA INVESTMENTS, LP | $11,475,213 | 2,693,712 | 2.05% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11,070,577 | 2,598,727 | 1.97% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $9,358,279 | 2,196,779 | 1.67% | Shares |
| BANK OF AMERICA CORP /DE/ | $8,689,749 | 2,039,847 | 1.55% | Shares |
| GOLDMAN SACHS GROUP INC | $6,332,618 | 1,486,530 | 1.13% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5,030,221 | 1,180,803 | 0.90% | Shares |
| BlackRock, Inc. | $4,766,748 | 1,118,955 | 0.85% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $4,486,321 | 1,053,127 | 0.80% | Shares |
| Caption Management, LLC | $4,260,000 | 1,000,000 | 0.76% | Put option |
| J. Goldman & Co LP | $3,478,669 | 816,589 | 0.62% | Shares |
| WELLS FARGO & COMPANY/MN | $3,473,987 | 815,490 | 0.62% | Shares |
| SCOPIA CAPITAL MANAGEMENT LP | $2,960,534 | 694,961 | 0.53% | Shares |
| Balyasny Asset Management L.P. | $2,914,296 | 684,107 | 0.52% | Shares |
| TWO SIGMA ADVISERS, LP | $2,897,166 | 510,964 | 0.52% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $2,771,407 | 650,565 | 0.49% | Shares |
| Swiss National Bank | $2,502,324 | 587,400 | 0.45% | Shares |
| STATE OF WISCONSIN INVESTMENT BOARD | $2,177,052 | 511,045 | 0.39% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2,106,540 | 494,493 | 0.38% | Shares |
| 1492 Capital Management LLC | $2,052,136 | 481,722 | 0.37% | Shares |
| Mariner, LLC | $2,020,189 | 474,236 | 0.36% | Shares |
| MILLENNIUM MANAGEMENT LLC | $1,836,597 | 431,126 | 0.33% | Shares |
| Schonfeld Strategic Advisors LLC | $1,774,216 | 416,483 | 0.32% | Shares |
| Squarepoint Ops LLC | $1,759,644 | 413,062 | 0.31% | Shares |
| Jefferies Financial Group Inc. | $1,694,202 | 397,700 | 0.30% | Shares |
| ExodusPoint Capital Management, LP | $1,666,261 | 391,141 | 0.30% | Shares |
| JANE STREET GROUP, LLC | $1,658,418 | 389,300 | 0.30% | Call option |
| Man Group plc | $1,624,023 | 381,226 | 0.29% | Shares |
| RHUMBLINE ADVISERS | $1,604,647 | 376,681 | 0.29% | Shares |
| IEQ CAPITAL, LLC | $1,544,607 | 362,584 | 0.28% | Shares |
| CITIGROUP INC | $1,499,243 | 351,935 | 0.27% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,423,692 | 334,200 | 0.25% | Put option |
| Bank of New York Mellon Corp | $1,422,222 | 333,855 | 0.25% | Shares |
| Caption Management, LLC | $1,414,231 | 331,979 | 0.25% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1,359,221 | 319,066 | 0.24% | Shares |
| ALPS ADVISORS INC | $1,330,615 | 312,351 | 0.24% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,216,230 | 285,500 | 0.22% | Call option |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1,029,075 | 241,567 | 0.18% | Shares |
| BARCLAYS PLC | $1,029,062 | 241,564 | 0.18% | Shares |
| Rafferty Asset Management, LLC | $1,008,640 | 236,770 | 0.18% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $1,002,715 | 235,379 | 0.18% | Shares |
| Aaron Wealth Advisors LLC | $1,000,878 | 234,948 | 0.18% | Shares |
| HSBC HOLDINGS PLC | $998,560 | 230,881 | 0.18% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $930,294 | 379,712 | 0.17% | Shares |
| CITADEL ADVISORS LLC | $928,680 | 218,000 | 0.17% | Call option |
| CITADEL ADVISORS LLC | $898,860 | 211,000 | 0.16% | Put option |
| Bruce & Co., Inc. | $831,011 | 195,073 | 0.15% | Shares |
| VANGUARD ASSET MANAGEMENT, Ltd | $775,060 | 181,939 | 0.14% | Shares |
| MetLife Investment Management, LLC | $766,442 | 179,916 | 0.14% | Shares |
| FRANKLIN RESOURCES INC | $755,021 | 177,235 | 0.13% | Shares |
| Stonepine Capital Management, LLC | $750,000 | 250,000 | 0.13% | Call option |
| UBS Group AG | $715,978 | 168,070 | 0.13% | Shares |
| ALLIANCEBERNSTEIN L.P. | $693,375 | 283,010 | 0.12% | Shares |
| MORGAN STANLEY | $651,282 | 152,883 | 0.12% | Shares |
| TUDOR INVESTMENT CORP ET AL | $640,657 | 150,389 | 0.11% | Shares |
| RAYMOND JAMES FINANCIAL INC | $632,009 | 148,359 | 0.11% | Shares |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $613,437 | 171,372 | 0.11% | Shares |
| Jain Global LLC | $604,673 | 141,942 | 0.11% | Shares |
| KING LUTHER CAPITAL MANAGEMENT CORP | $590,457 | 138,605 | 0.11% | Shares |
| Susquehanna Portfolio Strategies, LLC | $574,538 | 134,868 | 0.10% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $570,354 | 133,886 | 0.10% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $557,723 | 130,921 | 0.10% | Shares |
| PROFUND ADVISORS LLC | $517,726 | 121,532 | 0.09% | Shares |
| Invesco Ltd. | $512,389 | 120,279 | 0.09% | Shares |
| Vanguard Global Advisers, LLC | $509,833 | 119,679 | 0.09% | Shares |
| KLP KAPITALFORVALTNING AS | $491,604 | 115,400 | 0.09% | Shares |
| Gotham Asset Management, LLC | $452,463 | 106,212 | 0.08% | Shares |
| State of New Jersey Common Pension Fund D | $403,171 | 94,641 | 0.07% | Shares |
| State of Wyoming | $403,149 | 94,636 | 0.07% | Shares |
| Police & Firemen's Retirement System of New Jersey | $386,834 | 90,806 | 0.07% | Shares |
| Amundi | $374,310 | 87,866 | 0.07% | Shares |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $373,478 | 87,671 | 0.07% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $359,966 | 84,499 | 0.06% | Shares |
| ARIZONA STATE RETIREMENT SYSTEM | $344,050 | 80,763 | 0.06% | Shares |
| Mitsubishi UFJ Asset Management Co., Ltd. | $338,155 | 79,379 | 0.06% | Shares |
| Aquatic Capital Management LLC | $335,300 | 78,709 | 0.06% | Shares |
| Rockefeller Capital Management L.P. | $332,996 | 78,168 | 0.06% | Shares |
| Vanguard Investments Australia, Ltd. | $314,929 | 73,927 | 0.06% | Shares |
| JANUS HENDERSON GROUP PLC | $313,658 | 127,763 | 0.06% | Shares |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $312,203 | 73,287 | 0.06% | Shares |
| Sequoia Financial Advisors, LLC | $296,935 | 69,703 | 0.05% | Shares |
| INTECH INVESTMENT MANAGEMENT LLC | $284,653 | 66,820 | 0.05% | Shares |
| COMMONWEALTH EQUITY SERVICES, LLC | $280,421 | 65,827 | 0.05% | Shares |
| China Universal Asset Management Co., Ltd. | $262,714 | 61,670 | 0.05% | Shares |
| LPL Financial LLC | $260,060 | 61,047 | 0.05% | Shares |
| SIMPLEX TRADING, LLC | $258,790 | 60,749 | 0.05% | Shares |
| Cetera Investment Advisers | $241,546 | 56,701 | 0.04% | Shares |
| Painted Porch Advisors LLC | $227,620 | 53,432 | 0.04% | Shares |
Company insiders 43 insiders · 27 officers · 18 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Michael Castagna | Chief Executive Officer | July 15, 2026 M | 2,433,779 | 1 | 4 | $-990,292 |
| Hakan Edstrom | President & CEO | Aug. 27, 2015 A | 1,114,340 | 0 | 0 | $0 |
| Christopher B Prentiss | Chief Financial Officer | July 15, 2026 F | 318,668 | 0 | 0 | $0 |
| Juergen Martens | Corporate VP and COO | Aug. 27, 2015 A | 106,539 | 0 | 0 | $0 |
| Dominic Marasco | Pres, Endocrine Business Unit | July 15, 2026 F | 343,398 | 0 | 0 | $0 |
| Sanjay R Singh | EVP Technical Operations | July 15, 2026 M | 478,966 | 0 | 1 | $-94,448 |
| Stuart A Tross | Chief People & Workpl Officer | July 15, 2026 M | 1,058,142 | 0 | 2 | $-548,528 |
| David Thomson | EVP Genl Counsel & Secretary | July 15, 2026 M | 797,554 | 0 | 3 | $-930,755 |
| Ajay Ahuja | Chief Medical Officer | March 23, 2026 A | 318,200 | 0 | 0 | $0 |
| Lauren M Sabella | EVP Operations | July 15, 2025 F | 349,841 | 0 | 0 | $0 |
| Burkhard Blank | EVP Chief Medical Officer | July 15, 2025 F | 460,791 | 0 | 0 | $0 |
| Joseph Kocinsky | Chief Technology Officer | Aug. 27, 2022 F | 745,233 | 0 | 0 | $0 |
| Alejandro Galindo | EVP Endocrine Business Unit | Feb. 28, 2022 A | 576,690 | 0 | 0 | $0 |
| Rosabel Realica Alinaya | VP, IR & Treasury | Aug. 27, 2020 A | 167,119 | 0 | 0 | $0 |
| David M Kendall | Chief Medical Officer | July 31, 2020 P | 41,059 | 0 | 0 | $0 |
| Patrick Mccauley | Chief Commercial Officer | Feb. 25, 2020 A | 83,972 | 0 | 0 | $0 |
| Courtney Barton | Chief Compl & Privacy Officer | July 31, 2019 P | 29,584 | 0 | 0 | $0 |
| Elizabeth Garrett Ingram | Chief Marketing Officer | May 14, 2019 A | 43,012 | 0 | 0 | $0 |
| Raymond W. Urbanski | Corp VP, CMO | Aug. 10, 2017 S | 2,924 | 0 | 0 | $0 |
| Linda A Adreveno | Sr. VP, HR | Feb. 18, 2016 A | 92,200 | 0 | 0 | $0 |
| Alfred E Mann | Executive Chairman | Aug. 22, 2015 F | 1,005,990 | 0 | 0 | $0 |
| Diane Palumbo | Vice President, Human Resource | Feb. 23, 2015 F | 50,624 | 0 | 0 | $0 |
| Peter C Richardson | Chief Scientific Officer | March 3, 2012 F | 133,611 | 0 | 0 | $0 |
| Richard L Anderson | Corporate VP | Nov. 16, 2008 F | 204,401 | 0 | 0 | $0 |
| John R. Riesenberger | VP & Chief Commercial Officer | Aug. 13, 2008 A | 14,650 | 0 | 0 | $0 |
| Dan Burns | VP & President, MKBP | Dec. 8, 2006 A | 14,800 | 0 | 0 | $0 |
| Wendell W Cheatham | VP, Medical & Reg Affairs | Aug. 19, 2004 A | 300 | 0 | 0 | $0 |
| Sabrina Kay | Director | May 20, 2026 A | 265,600 | 0 | 0 | $0 |
| Jennifer Grancio | Director | May 20, 2026 A | 244,815 | 0 | 0 | $0 |
| James Samuel Shannon | Director | May 20, 2026 A | 64,635 | 0 | 0 | $0 |
| Michael A Friedman | Director | May 20, 2026 A | 47,500 | 0 | 0 | $0 |
| Anthony C Hooper | Director | May 20, 2026 A | 236,153 | 0 | 0 | $0 |
| Christine Mundkur | Director | May 20, 2026 A | 254,493 | 0 | 0 | $0 |
| Ronald J Consiglio | Director | May 20, 2026 A | 132,342 | 0 | 0 | $0 |
| Kent Kresa | Director | May 15, 2024 A | 274,541 | 0 | 0 | $0 |
| Henry L Nordhoff | Director | May 14, 2019 A | 103,426 | 0 | 0 | $0 |
| David Maccallum | Director | May 16, 2018 A | 114,790 | 0 | 0 | $0 |
| Matthew J Pfeffer | Director | Aug. 28, 2017 F | 81,961 | 0 | 0 | $0 |
| Abraham E Cohen | Director | Aug. 17, 2012 S | 56,424 | 0 | 0 | $0 |
| Heather Hay Murren | Director | Aug. 13, 2008 A | 10,100 | 0 | 0 | $0 |
| Kathleen Connell | Director | May 25, 2006 A | — | 0 | 0 | $0 |
| Llew Keltner | Director | May 25, 2006 A | — | 0 | 0 | $0 |
| Steven B. Binder | — | Aug. 7, 2026 S | 785,867 | 0 | 3 | $-427,369 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Alfred E. Mann, Alfred E. Mann Living Trust, Biomed Partners, LLC, Minimed Infusion, Inc., The Mann Group LLC ×2 filings | July 10, 2012 | — | Initial filing | — | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | Jan. 31, 2006 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 41 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| RNIN · EA Series Trust | 1.43% | 773,251 NS | April 30, 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0.74% | 317,578 NS | May 31, 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.54% | 29,662 SH | Aug. 8, 2026 | Daily |
| AGNG · Global X Funds | 0.46% | 98,947 NS | May 31, 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.34% | 625,921 NS | April 30, 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0.11% | 64,525 NS | May 31, 2026 | N-PORT |
| IBB · iShares Trust | 0.09% | 2,170,137 SH | Aug. 8, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.09% | 16,814 SH | Aug. 8, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.08% | 330,117 SH | Aug. 8, 2026 | Daily |
| IWO · iShares Trust | 0.07% | 2,772,931 SH | Aug. 8, 2026 | Daily |
| ESML · iShares Trust | 0.06% | 449,515 SH | Aug. 8, 2026 | Daily |
| BIB · ProShares Trust | 0.06% | 11,389 NS | May 31, 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.04% | 114,273 NS | April 30, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.04% | 1,771,496 SH | Aug. 8, 2026 | Daily |
| IWM · iShares Trust | 0.04% | 7,830,029 SH | Aug. 8, 2026 | Daily |
| ISCG · iShares Trust | 0.04% | 94,032 SH | Aug. 8, 2026 | Daily |
| ITWO · ProShares Trust | 0.03% | 14,400 NS | May 31, 2026 | N-PORT |
| RSSL · Global X Funds | 0.03% | 132,607 NS | April 30, 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.02% | 1,466,402 NS | May 31, 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.02% | 61,465 NS | May 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.02% | 874,372 SH | Aug. 8, 2026 | Daily |
| ISCB · iShares Trust | 0.02% | 13,557 SH | Aug. 8, 2026 | Daily |
| UWM · ProShares Trust | 0.02% | 11,261 NS | May 31, 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 135,688 NS | April 30, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 638,128 NS | April 30, 2026 | N-PORT |
| URTY · ProShares Trust | 0.01% | 11,390 NS | May 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 3,543,398 SH | Aug. 8, 2026 | Daily |
| WSML · iShares Trust | 0.01% | 16,464 SH | Aug. 8, 2026 | Daily |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 12,000 NS | May 31, 2026 | N-PORT |
| HDG · ProShares Trust | 0.01% | 286 NS | May 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 452,118 NS | April 30, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 27,701 NS | April 30, 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.00% | 1,330 NS | May 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 465,445 SH | Aug. 8, 2026 | Daily |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 196,006 NS | May 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 83,220 SH | Aug. 8, 2026 | Daily |
| TILT · FlexShares Trust | 0.00% | 10,345 NS | April 30, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 32,093 NS | April 30, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 14,557 NS | April 30, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 9,327,332 SH | Aug. 8, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 26,184 SH | Aug. 8, 2026 | Daily |